316 related articles for article (PubMed ID: 16440205)
1. [Value of surfactant replacement therapy in the treatment of acute respiratory distress syndrome].
Lauer S; Fischer LG; Stubbe HD; Van Aken H; Westphal M
Anaesthesist; 2006 Apr; 55(4):433-42. PubMed ID: 16440205
[TBL] [Abstract][Full Text] [Related]
2. The role of exogenous surfactant in the treatment of acute lung injury.
Lewis JF; Veldhuizen R
Annu Rev Physiol; 2003; 65():613-42. PubMed ID: 12517997
[TBL] [Abstract][Full Text] [Related]
3. The future of surfactant therapy during ALI/ARDS.
Lewis JF; Veldhuizen RA
Semin Respir Crit Care Med; 2006 Aug; 27(4):377-88. PubMed ID: 16909371
[TBL] [Abstract][Full Text] [Related]
4. Surfactant replacement therapy for adult respiratory distress syndrome in children.
Evans DA; Wilmott RW; Whitsett JA
Pediatr Pulmonol; 1996 May; 21(5):328-36. PubMed ID: 8726159
[TBL] [Abstract][Full Text] [Related]
5. Exogenous natural surfactant for treatment of acute lung injury and the acute respiratory distress syndrome.
Kesecioglu J; Beale R; Stewart TE; Findlay GP; Rouby JJ; Holzapfel L; Bruins P; Steenken EJ; Jeppesen OK; Lachmann B
Am J Respir Crit Care Med; 2009 Nov; 180(10):989-94. PubMed ID: 19713451
[TBL] [Abstract][Full Text] [Related]
6. Experimental models of acute respiratory distress syndrome: clinical relevance and response to surfactant therapy.
Kobayashi T; Tashiro K; Cui X; Konzaki T; Xu Y; Kabata C; Yamamoto K
Biol Neonate; 2001 May; 80 Suppl 1():26-8. PubMed ID: 11359042
[TBL] [Abstract][Full Text] [Related]
7. Surfactant: current and potential therapeutic application in infants and adults.
Lewis J; Veldhuizen RA
J Aerosol Med; 1996; 9(1):143-54. PubMed ID: 10160204
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approach to a child with acute respiratory distress syndrome: a report of two cases.
Nosal S; Durdik P; Luptakova A; Sutovska M; Nosal V; Jesenak M; Havlicekova Z; Hamzik J; Banovcin P
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():43-51. PubMed ID: 19218632
[TBL] [Abstract][Full Text] [Related]
9. [Surfactant replacement therapy increases life-span of patients with acute respiratory distress syndrome].
Potapov AL; Novikov NIu; Tumanskiĭ VA; Babanin AA
Klin Khir; 2013 Feb; (2):57-9. PubMed ID: 23705485
[TBL] [Abstract][Full Text] [Related]
10. Exogenous surfactant in paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome.
Playfor SD; Nootigattu VK
Curr Drug Saf; 2006 May; 1(2):159-68. PubMed ID: 18690927
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.
Anzueto A; Baughman RP; Guntupalli KK; Weg JG; Wiedemann HP; Raventós AA; Lemaire F; Long W; Zaccardelli DS; Pattishall EN
N Engl J Med; 1996 May; 334(22):1417-21. PubMed ID: 8618579
[TBL] [Abstract][Full Text] [Related]
12. Exogenous surfactant therapy for ARDS.
Maruscak A; Lewis JF
Expert Opin Investig Drugs; 2006 Jan; 15(1):47-58. PubMed ID: 16370933
[TBL] [Abstract][Full Text] [Related]
13. The future of exogenous surfactant therapy.
Willson DF; Notter RH
Respir Care; 2011 Sep; 56(9):1369-86; discussion 1386-8. PubMed ID: 21944686
[TBL] [Abstract][Full Text] [Related]
14. Exogenous surfactant replacement in ARDS--one day, someday, or never?
Baudouin SV
N Engl J Med; 2004 Aug; 351(9):853-5. PubMed ID: 15329420
[No Abstract] [Full Text] [Related]
15. Treatment of acute (Adult) respiratory distress syndrome. The holy grail of surfactant therapy.
Taeusch HW
Biol Neonate; 2000 May; 77 Suppl 1():2-8. PubMed ID: 10828579
[TBL] [Abstract][Full Text] [Related]
16. The adult respiratory distress syndrome: first trials with surfactant replacement.
Richman PS; Spragg RG; Robertson B; Merritt TA; Curstedt T
Eur Respir J Suppl; 1989 Mar; 3():109s-111s. PubMed ID: 2742681
[TBL] [Abstract][Full Text] [Related]
17. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome.
Weg JG; Balk RA; Tharratt RS; Jenkinson SG; Shah JB; Zaccardelli D; Horton J; Pattishall EN
JAMA; 1994 Nov; 272(18):1433-8. PubMed ID: 7933425
[TBL] [Abstract][Full Text] [Related]
18. Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS).
Robertson B
Monaldi Arch Chest Dis; 1998 Feb; 53(1):64-9. PubMed ID: 9632910
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing efficacy of exogenous surfactant in acute lung injury.
Lewis JF; Veldhuizen RA
Biol Neonate; 1995; 67 Suppl 1():48-60. PubMed ID: 7647158
[TBL] [Abstract][Full Text] [Related]
20. Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome--where do we go from here?
Dushianthan A; Cusack R; Goss V; Postle AD; Grocott MP
Crit Care; 2012 Nov; 16(6):238. PubMed ID: 23171712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
